Results 141 to 150 of about 49,177 (212)

Factors Predicting the Efficacy of Valbenazine and Exacerbation of Tardive Dyskinesia After Valbenazine Discontinuation in Japanese Patients: A Post Hoc Analysis of the J-KINECT Study. [PDF]

J Clin Psychopharmacol
Watanabe Y, Susuta Y, Masui H, Takeuchi H.   +3 more
europepmc   +1 more source

Reporting Frequency of Antipsychotics-Induced Tardive Dyskinesia and Other Extrapyramidal Symptoms: Analysis Based on a Spontaneous Reporting System Database in Japan. [PDF]

Neuropsychopharmacol Rep
Saga Y, Horio H, Chiang CL, Wakamatsu A.
europepmc   +1 more source

A tardive dyskinesia drug target VMAT-2 participates in neuronal process elongation. [PDF]

Sci Rep
Ishida M, Ichikawa R, Ohbuchi K, Oizumi H, Miyamoto Y, Yamauchi J.   +5 more
europepmc   +1 more source

Identifying the diagnostic gap of tardive dyskinesia: an analysis of semi-structured electronic health record data. [PDF]

BMC Psychiatry
Griffiths K, Won Y, Lee Z, Wang L, Correll CU, Patel R.   +5 more
europepmc   +1 more source

Correction: Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease. [PDF]

Neurol Ther
Frank S, Anderson KE, Fernandez HH, Hauser RA, Claassen DO, Stamler D, Factor SA, Jimenez-Shahed J, Barkay H, Wilhelm A, Alexander JK, Chaijale N, Barash S, Savola JM, Gordon MF, Chen M.   +15 more
europepmc   +1 more source

Treatment of tardive dyskinesia with clonazepam: A case report. [PDF]

Clin Case Rep
Chhetri B, Gyeltshen D.
europepmc   +1 more source